Enanta Pharmaceuticals, a company in the biomedical and genetics industry, outperformed market gains this year.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Enanta Pharmaceuticals, a company in the biomedical and genetics industry, outperformed market gains this year.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Enanta Pharmaceuticals (United States)
company in Watertown, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksEnanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of